Beta Bionics, Inc.
BBNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $150,406 | $125,326 | $118,091 |
| - Cash | $30,432 | $26,566 | $27,675 |
| + Debt | $7,255 | $4,223 | $4,133 |
| Enterprise Value | $127,229 | $102,983 | $94,549 |
| Revenue | $65,124 | $11,995 | $179 |
| % Growth | 442.9% | 6,601.1% | – |
| Gross Profit | $35,888 | $6,308 | $179 |
| % Margin | 55.1% | 52.6% | 100% |
| EBITDA | -$44,100 | -$34,624 | -$63,399 |
| % Margin | -67.7% | -288.7% | -35,418.4% |
| Net Income | -$54,756 | -$44,099 | -$64,751 |
| % Margin | -84.1% | -367.6% | -36,173.7% |
| EPS Diluted | -8.6 | -8.31 | -12.96 |
| % Growth | -3.5% | 35.9% | – |
| Operating Cash Flow | -$48,273 | -$32,445 | -$60,208 |
| Capital Expenditures | -$3,395 | -$402 | -$772 |
| Free Cash Flow | -$51,668 | -$32,847 | -$60,980 |